Intuitively, R&D, accounting for about 20% of drug revenue, would be reduced as profit declines. The Congressional Budget Office (CBO) estimated that:
Biotech startups
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
